ATE237349T1 - Fat-binding polymers - Google Patents

Fat-binding polymers

Info

Publication number: ATE237349T1
Authority: AT; Austria
Prior art keywords: fat; polymers; binding polymers; binding; methods
Prior art date: 1998-01-09

Application number

AT99900369T

Other languages

English (en)

Inventor

W Harry Mandeville Iii

George M Whitesides

Stephen Randall Holmes-Farley

Original Assignee

Geltex Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-09

Filing date

1999-01-04

Publication date

2003-05-15

1998-10-05 Priority claimed from US09/166,453 external-priority patent/US6264937B1/en

1999-01-04 Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE237349T1 publication Critical patent/ATE237349T1/de

Links

229920000642 polymer Polymers 0.000 title abstract 5
238000000034 method Methods 0.000 abstract 5
229940127470 Lipase Inhibitors Drugs 0.000 abstract 1
SIKWOTFNWURSAY-UHFFFAOYSA-N Lipstatin Natural products CCCCCCC1C(CC(CC=CCC=CCCCCC)C(=O)OC(CC(C)C)NC=O)OC1=O SIKWOTFNWURSAY-UHFFFAOYSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
AHLBNYSZXLDEJQ-UHFFFAOYSA-N N-formyl-L-leucylester Natural products CCCCCCCCCCCC(OC(=O)C(CC(C)C)NC=O)CC1OC(=O)C1CCCCCC AHLBNYSZXLDEJQ-UHFFFAOYSA-N 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
235000013367 dietary fats Nutrition 0.000 abstract 1
230000029087 digestion Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
OQMAKWGYQLJJIA-CUOOPAIESA-N lipstatin Chemical compound CCCCCC[C@H]1[C@H](C[C@H](C\C=C/C\C=C/CCCCC)OC(=O)[C@H](CC(C)C)NC=O)OC1=O OQMAKWGYQLJJIA-CUOOPAIESA-N 0.000 abstract 1
231100000053 low toxicity Toxicity 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
229960001243 orlistat Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polyesters Or Polycarbonates (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Medicinal Preparation (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Detergent Compositions (AREA)

AT99900369T 1998-01-09 1999-01-04 Fat-binding polymers ATE237349T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US496398A	1998-01-09	1998-01-09
US09/166,453 US6264937B1 (en)	1998-01-09	1998-10-05	Fat-binding polymers
PCT/US1999/000028 WO1999034787A2 (en)	1998-01-09	1999-01-04	Fat-binding polymers

Publications (1)

Publication Number	Publication Date
ATE237349T1 true ATE237349T1 (en)	2003-05-15

Family

ID=26673719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99900369T ATE237349T1 (en)	1998-01-09	1999-01-04	Fat-binding polymers

Country Status (18)

Country	Link
EP (1)	EP1043981B1 (de)
JP (1)	JP2002500183A (de)
KR (2)	KR100773625B1 (de)
CN (1)	CN1212123C (de)
AT (1)	ATE237349T1 (de)
AU (2)	AU740233B2 (de)
BR (1)	BR9907234A (de)
CA (1)	CA2318417A1 (de)
DE (1)	DE69906928T2 (de)
ES (1)	ES2200493T3 (de)
HU (1)	HUP0100890A3 (de)
IL (1)	IL137096A (de)
MX (1)	MX222446B (de)
NO (1)	NO20003510L (de)
NZ (2)	NZ523301A (de)
PL (1)	PL193452B1 (de)
RU (1)	RU2222335C2 (de)
WO (1)	WO1999034787A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6267952B1 (en) *	1998-01-09	2001-07-31	Geltex Pharmaceuticals, Inc.	Lipase inhibiting polymers
WO2001005408A1 (en) *	1999-07-14	2001-01-25	Geltex Pharmaceuticals, Inc.	Fat-binding polymers, optionally combined with lipase inhibitors
KR20020068511A (ko) *	1999-10-01	2002-08-27	아마토 세이야쿠 가부시키가이샤	항비만치료제
CZ302087B6 (cs)	2000-07-28	2010-10-06	F. Hoffmann-La Roche Ag	Farmaceutický prípravek obsahující orlistat spolu se sekvestrantem žlucových kyselin pro použití pro lécení a prevenci obezity
JP2004526778A (ja) *	2001-04-18	2004-09-02	ジェンザイムコーポレーション	脂肪族ポリアミンを用いるｘ症候群の処置方法
US8372430B2 (en)	2002-12-17	2013-02-12	The Procter & Gamble Company	Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
SE0302253D0 (sv) *	2003-08-21	2003-08-21	Forskarpatent I Syd Ab	Lipase-colipase inhibitor
CN106176800B (zh) *	2016-07-11	2019-12-06	韩源平	多聚阳离子树脂的制药应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7017227A (de) *	1969-12-27	1971-06-29
US4211765A (en) *	1971-10-12	1980-07-08	Monsanto Company	Method for controlling obesity
US4432968A (en) *	1980-10-20	1984-02-21	The Dow Chemical Company	Weight control with fat imbibing polymers
AU7653081A (en) *	1980-10-20	1982-04-29	Dow Chemical Company, The	T-butylstyrene copolymers for controlling body weight of animals
EP0354948A1 (de) *	1988-02-12	1990-02-21	DE ZAEPFFEL, Brigitte	Hydrophiles, vernetztes copolymer zur medizinischen und paramedizinischen verwendung
RU2066185C1 (ru) *	1993-01-11	1996-09-10	Институт пищевых веществ РАН	Гиполипидемический энтеросорбент
JP3507523B2 (ja) *	1993-05-12	2004-03-15	積水化学工業株式会社	糖質吸収抑制剤

1999
- 1999-01-04 HU HU0100890A patent/HUP0100890A3/hu unknown
- 1999-01-04 AT AT99900369T patent/ATE237349T1/de not_active IP Right Cessation
- 1999-01-04 ES ES99900369T patent/ES2200493T3/es not_active Expired - Lifetime
- 1999-01-04 IL IL137096A patent/IL137096A/en active IP Right Grant
- 1999-01-04 KR KR1020007007608A patent/KR100773625B1/ko not_active Expired - Fee Related
- 1999-01-04 CN CNB998020311A patent/CN1212123C/zh not_active Expired - Fee Related
- 1999-01-04 WO PCT/US1999/000028 patent/WO1999034787A2/en not_active Ceased
- 1999-01-04 EP EP99900369A patent/EP1043981B1/de not_active Expired - Lifetime
- 1999-01-04 NZ NZ523301A patent/NZ523301A/en unknown
- 1999-01-04 RU RU2000120918/14A patent/RU2222335C2/ru not_active IP Right Cessation
- 1999-01-04 KR KR1020067021186A patent/KR20060111741A/ko not_active Ceased
- 1999-01-04 DE DE69906928T patent/DE69906928T2/de not_active Expired - Fee Related
- 1999-01-04 AU AU19505/99A patent/AU740233B2/en not_active Ceased
- 1999-01-04 CA CA002318417A patent/CA2318417A1/en not_active Abandoned
- 1999-01-04 PL PL343898A patent/PL193452B1/pl unknown
- 1999-01-04 BR BR9907234-3A patent/BR9907234A/pt not_active Application Discontinuation
- 1999-01-04 JP JP2000527238A patent/JP2002500183A/ja active Pending
- 1999-01-04 NZ NZ505294A patent/NZ505294A/xx unknown
2000
- 2000-07-06 MX MXPA00006681 patent/MX222446B/es active IP Right Grant
- 2000-07-07 NO NO20003510A patent/NO20003510L/no not_active Application Discontinuation
2002
- 2002-02-01 AU AU2002014755A patent/AU2002014755A1/xx not_active Withdrawn

Also Published As

Publication number	Publication date
BR9907234A (pt)	2000-10-10
KR20010034013A (ko)	2001-04-25
WO1999034787A3 (en)	2000-01-20
HUP0100890A3 (en)	2001-12-28
KR100773625B1 (ko)	2007-11-05
IL137096A (en)	2006-10-31
RU2222335C2 (ru)	2004-01-27
HUP0100890A2 (hu)	2001-08-28
MX222446B (en)	2004-09-01
IL137096A0 (en)	2001-06-14
EP1043981A2 (de)	2000-10-18
NZ523301A (en)	2005-11-25
CN1288381A (zh)	2001-03-21
AU1950599A (en)	1999-07-26
KR20060111741A (ko)	2006-10-27
PL343898A1 (en)	2001-09-10
AU740233B2 (en)	2001-11-01
NO20003510D0 (no)	2000-07-07
DE69906928T2 (de)	2004-02-19
PL193452B1 (pl)	2007-02-28
MXPA00006681A (es)	2001-02-01
ES2200493T3 (es)	2004-03-01
CA2318417A1 (en)	1999-07-15
AU2002014755A1 (en)	2002-03-14
EP1043981B1 (de)	2003-04-16
HK1034044A1 (en)	2001-10-12
JP2002500183A (ja)	2002-01-08
CN1212123C (zh)	2005-07-27
DE69906928D1 (de)	2003-05-22
WO1999034787A2 (en)	1999-07-15
NO20003510L (no)	2000-09-07
NZ505294A (en)	2003-02-28

Similar Documents

Publication	Publication Date	Title
EP1736152A3 (de)	2009-10-07	Physiologisch stabile Butlersäurepräparate, und Butlersäuresalze und Derivate zur Behandlung von Wunden
YU77000A (sh)	2003-08-29	Primena peg-ifn-alfa i ribavirina za lečenje hroničnog hepatitisa c
AU2002236765A1 (en)	2002-07-30	Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
UA88270C2 (ru)	2009-10-12	Фармацевтический препарат и его применение для профилактики удара, диабета
EP1702618A3 (de)	2006-12-27	Zusammensetzungen und verwendungen von et743 in kombinationstherapie zur behandlung von krebs
WO2001005408A8 (en)	2001-07-19	Fat-binding polymers, optionally combined with lipase inhibitors
NO990934L (no)	1999-04-14	Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
EP0957925A4 (de)	2002-07-24	Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
ATE237349T1 (en)	2003-05-15	Fat-binding polymers
GB0020504D0 (en)	2000-10-11	Therapeutic method
BR0307022A (pt)	2004-11-03	Método de tratamento de um paciente que precisa de analgesia
SE9902597D0 (sv)	1999-07-06	New use
CZ223199A3 (cs)	1999-11-17	Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
WO1997026880A3 (en)	1997-09-12	Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
WO2002076393A3 (en)	2003-04-03	Antiagionecic, antitumor, chemopreventative agents
NO984196D0 (no)	1998-09-11	Fremgangsmåte for behandling av stoffmisbruk
KR960003741A (ko)	1996-02-23	조골세포 증식인자
IL129267A (en)	2003-10-31	Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
MD1469F1 (en)	2000-05-31	Method of treatment of the burn shock
EP1512413A3 (de)	2009-09-23	Pharmazeutische Mischung gegen Krebs, die ein 4-Chinazolinamin in Kombination mit einem anderen antineoplastischen Wirkstoff enthält
WO2000023058A3 (en)	2000-07-06	Use of an antianaerobic-bacterial or/and antiprotozoal agent (preferably metronidazole) in the manufacture of a medicament for the treatment of haemorrhoids
UA28928A (uk)	2000-10-16	Спосіб лікування гнійно-запальних захворювань м'яких тканин
UA37346A (uk)	2001-05-15	Спосіб імунокорекції при лікуванні загострень хронічних обструктивних захворювань легенів
MD1296F1 (en)	1999-08-30	The Nicolau method of treatment of the lichen planus
UA29280A (uk)	2000-10-16	Спосіб лікування флегмони шлунку

Legal Events

Date

Code

Title

Description

2003-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1043981

Country of ref document: EP

2004-01-15

EEIH

Change in the person of patent owner

2008-10-15

REN

Ceased due to non-payment of the annual fee